Aktiengesellschaft Bayer Crispr Therapeutics Ag

As of January 30, 2018


Aktiengesellschaft Bayer Net Worth

  • Net worth is estimated to be at least $2.76B
  • Owns at least 5,708,747 units of Crispr Therapeutics Ag stock

Aktiengesellschaft Bayer Trading

  • Largest purchase of shares was 527,472 units , worth over $12M on January 30, 2018
  • In total has made about 1 transaction recently
  • Usually trades in January, with the busiest year in 2018

AKTIENGESELLSCHAFT BAYER, BV Investments Global Bayer

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Aktiengesellschaft Bayer Mailing Address

  • Mailing address is Bayerwerk, Gebaeude W11 Kaiser-Wilhelm-Allee Leverkusen 2M D-51368 Germany

Crispr Therapeutics Ag Insider Trading

  • The most recent transaction was 25,000 units sold on August 10, 2021 by John Michael Tomsicek worth over $3.46M
  • In the last 5 years, insiders at Crispr Therapeutics Ag sold an estimated value of $382.19M and bought an estimated value of $55.06M
  • The most active traders are Samarth Kulkarni, Chief Executive Officer,  Bradley Bolzon, Director,  and Rodger Novak, President
  • Insider trading is most common in June, with the busiest year in 2017

CRISPR Therapeutics AG Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1